Hurricane Capital Advisors’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-533
Closed -$20.7K – 592
2023
Q4
$20.7K Buy
+533
New +$19.2K 0.01% 428

Other funds holding LYEL

Hurricane Capital Advisors's LYEL Position: Q1 2024 in Review

Hurricane Capital Advisors sold out of Lyell Immunopharma (LYEL) in Q1 2024, closing a stake of 533 shares — an estimated $20.7K sold.

Hurricane Capital Advisors first reported a position in LYEL in Q4 2023 and held it in 1 quarter. The position peaked at $20.7K in Q4 2023. 127 funds tracked by Wall St. Rank hold LYEL as of Q1 2024.

  • Hurricane Capital Advisors reported no remaining Lyell Immunopharma position as of Q1 2024 after selling out during the quarter.
  • Hurricane Capital Advisors sold 533 Lyell Immunopharma shares in Q1 2024, an estimated $20.7K.
  • Hurricane Capital Advisors first reported a position in Lyell Immunopharma in Q4 2023 and held it in 1 quarter.
  • Hurricane Capital Advisors's Lyell Immunopharma position peaked at $20.7K in Q4 2023.
  • 127 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q1 2024.

Based on Hurricane Capital Advisors's 13F filing for Q1 2024, filed 3 Nov 2026.